Roquette, a French multinational supplier of pharmaceutical and nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish start-up Biograil.
Roquette, a plant-based ingredients and pharmaceutical excipients manufacturer, announced today an agreement to acquire IFF Pharma Solutions, an excipients for oral dosage solutions producer, to reinforce its position as a major partner to the pharmaceutical industry.
French plant ingredients supplier Roquette, which is also is a leading player in naturally-derived pharmaceutical excipients, has agreed to acquire Qualicaps, a producer of hard capsules and pharmaceutical processing equipment for oral dosage.
Roquette, a French-based multinational provider of pharmaceutical and nutraceutical excipients, has opened a new Pharmaceutical Innovation Center near Philadelphia in Pennsylvania, USA, complementing its other centers in France and Singapore.
Roquette, a French-based provider of pharmaceutical and nutraceutical excipients, has acquired Crest Cellulose, an Indian excipient manufacturer, reinforcing its presence in India and Asia.
French firm Roquette has announced plans to spend €25 million to upgrade its liquid and powder polyols plant in Lestrem between 2022 and 2024. Roquette said the investment will strengthen its position as a leader in polyols and establish a strong reliable supply in the long term.
Plant ingredients supplier Roquette, which is also is a leading player in naturally-derived pharmaceutical excipients, has announced plans for a new innovation center at its US site in Spring House, Pennsylvania. The complex due to open in summer 2022 will house Roquette Pharmaceutical Solutions’ headquarters and serve as a global hub for R&D.
